Connect with us

News

Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio

gbafNews28

The liquid biopsy market is poised to grow by USD 4.02 billion during 2020-2024, progressing at a CAGR of almost 38% during the forecast period.

The report on the liquid biopsy market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing funding for liquid biopsy.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis

The liquid biopsy market analysis includes the technology segment and geographic landscapes. This study identifies the growing focus on personalized medicine for cancer care as one of the prime reasons driving the liquid biopsy market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The Liquid Biopsy Market covers the following areas:

Liquid Biopsy Market Sizing

Liquid Biopsy Market Forecast

Liquid Biopsy Market Analysis

Companies Mentioned

  • ANGLE Plc
  • Biocept Inc.
  • Bio-Techne Corp.
  • CIRCULOGENE
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • LungLife AI Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • SAGA Diagnostics AB

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 – 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Technology

  • Market segments
  • Comparison by Technology
  • CTC and ctDNA – Market size and forecast 2019-2024
  • Exosome and RNA – Market size and forecast 2019-2024
  • Market opportunity by Technology

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2019-2024
  • Europe – Market size and forecast 2019-2024
  • Asia – Market size and forecast 2019-2024
  • ROW – Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • ANGLE Plc
  • Biocept Inc.
  • Bio-Techne Corp.
  • CIRCULOGENE
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • LungLife AI Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • SAGA Diagnostics AB

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]

Website: www.technavio.com/

Advertisement
Editorial & Advertiser disclosure

Call for Entries

Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Newsletters with Secrets & Analysis. Subscribe Now

Recommended